Matches in SemOpenAlex for { <https://semopenalex.org/work/W3180913743> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W3180913743 endingPage "627" @default.
- W3180913743 startingPage "619" @default.
- W3180913743 abstract "To quantify the utility of a terminal-phase adjusted area under the concentration curve method in increasing the probability of a correct and conclusive outcome of a bioequivalence (BE) trial for highly variable drugs when clearance (CL) varies more than the volume of distribution (V).Data from a large population of subjects were generated with variability in CL and V, and used to simulate a two-period, two-sequence crossover BE trial. The 90% confidence interval for formulation comparison was determined following BE assessment using the area under the concentration curve (AUC) ratio test, and the proposed terminal-phase adjusted AUC ratio test. An outcome of bioequivalent, nonbioequivalent or inconclusive was then assigned according to predefined BE limits.When CL varied more than V, the proposed approach enhanced the probability of correctly assigning bioequivalent or nonbioequivalent and reduced the risk of an inconclusive trial. For a hypothetical drug with between-subject variability of 35% for CL and 10% for V, when the true test-reference ratio of bioavailability was 1.15, a crossover study of n = 14 subjects analysed by the proposed method would have 80% or 20% probability of claiming bioequivalent or nonbioequivalent, compared to 22%, 46% or 32% probability of claiming bioequivalent, nonbioequivalent or inconclusive using the standard AUC ratio test.The terminal-phase adjusted AUC ratio test represents a simple and readily applicable approach to enhance the BE assessment of drug products when CL varies more than V." @default.
- W3180913743 created "2021-07-19" @default.
- W3180913743 creator A5004605882 @default.
- W3180913743 creator A5039851568 @default.
- W3180913743 creator A5046686843 @default.
- W3180913743 creator A5054847813 @default.
- W3180913743 creator A5056248574 @default.
- W3180913743 date "2021-08-24" @default.
- W3180913743 modified "2023-09-25" @default.
- W3180913743 title "Evaluation of area under the concentration curve adjusted by the terminal‐phase as a metric to reduce the impact of variability in bioequivalence testing" @default.
- W3180913743 cites W2003426662 @default.
- W3180913743 cites W2026283367 @default.
- W3180913743 cites W2056624012 @default.
- W3180913743 cites W2102580822 @default.
- W3180913743 cites W2108950280 @default.
- W3180913743 cites W2139330669 @default.
- W3180913743 cites W2808753212 @default.
- W3180913743 cites W2902164115 @default.
- W3180913743 cites W2954920819 @default.
- W3180913743 cites W4239647612 @default.
- W3180913743 doi "https://doi.org/10.1111/bcp.14986" @default.
- W3180913743 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34272747" @default.
- W3180913743 hasPublicationYear "2021" @default.
- W3180913743 type Work @default.
- W3180913743 sameAs 3180913743 @default.
- W3180913743 citedByCount "1" @default.
- W3180913743 countsByYear W31809137432022 @default.
- W3180913743 crossrefType "journal-article" @default.
- W3180913743 hasAuthorship W3180913743A5004605882 @default.
- W3180913743 hasAuthorship W3180913743A5039851568 @default.
- W3180913743 hasAuthorship W3180913743A5046686843 @default.
- W3180913743 hasAuthorship W3180913743A5054847813 @default.
- W3180913743 hasAuthorship W3180913743A5056248574 @default.
- W3180913743 hasBestOaLocation W31809137431 @default.
- W3180913743 hasConcept C105795698 @default.
- W3180913743 hasConcept C142724271 @default.
- W3180913743 hasConcept C181389837 @default.
- W3180913743 hasConcept C204787440 @default.
- W3180913743 hasConcept C27081682 @default.
- W3180913743 hasConcept C2908647359 @default.
- W3180913743 hasConcept C33923547 @default.
- W3180913743 hasConcept C42404028 @default.
- W3180913743 hasConcept C44249647 @default.
- W3180913743 hasConcept C71924100 @default.
- W3180913743 hasConcept C76318530 @default.
- W3180913743 hasConcept C87813604 @default.
- W3180913743 hasConcept C98274493 @default.
- W3180913743 hasConcept C99454951 @default.
- W3180913743 hasConceptScore W3180913743C105795698 @default.
- W3180913743 hasConceptScore W3180913743C142724271 @default.
- W3180913743 hasConceptScore W3180913743C181389837 @default.
- W3180913743 hasConceptScore W3180913743C204787440 @default.
- W3180913743 hasConceptScore W3180913743C27081682 @default.
- W3180913743 hasConceptScore W3180913743C2908647359 @default.
- W3180913743 hasConceptScore W3180913743C33923547 @default.
- W3180913743 hasConceptScore W3180913743C42404028 @default.
- W3180913743 hasConceptScore W3180913743C44249647 @default.
- W3180913743 hasConceptScore W3180913743C71924100 @default.
- W3180913743 hasConceptScore W3180913743C76318530 @default.
- W3180913743 hasConceptScore W3180913743C87813604 @default.
- W3180913743 hasConceptScore W3180913743C98274493 @default.
- W3180913743 hasConceptScore W3180913743C99454951 @default.
- W3180913743 hasIssue "2" @default.
- W3180913743 hasLocation W31809137431 @default.
- W3180913743 hasLocation W31809137432 @default.
- W3180913743 hasOpenAccess W3180913743 @default.
- W3180913743 hasPrimaryLocation W31809137431 @default.
- W3180913743 hasRelatedWork W122950290 @default.
- W3180913743 hasRelatedWork W2044120869 @default.
- W3180913743 hasRelatedWork W2048588916 @default.
- W3180913743 hasRelatedWork W2368562612 @default.
- W3180913743 hasRelatedWork W2373452970 @default.
- W3180913743 hasRelatedWork W2380091905 @default.
- W3180913743 hasRelatedWork W2394399285 @default.
- W3180913743 hasRelatedWork W2414953822 @default.
- W3180913743 hasRelatedWork W2415829651 @default.
- W3180913743 hasRelatedWork W2416049168 @default.
- W3180913743 hasVolume "88" @default.
- W3180913743 isParatext "false" @default.
- W3180913743 isRetracted "false" @default.
- W3180913743 magId "3180913743" @default.
- W3180913743 workType "article" @default.